3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
8
Leukemia, Myeloid, Acute
5
Neuroblastoma
2
Neoplasms
2
Neoplasm Metastasis
2
Vaccinia
1
Thyroid Neoplasms
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Melanoma
1
Hepatoblastoma
1
Gastrointestinal Stromal Tumors
1
Fibrolamellar hepatocellular carcinoma
1
Interventions
Cyclophosphamide
31
Rituximab
26
Biopsy
23
Specimen Handling
21
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
14
Vincristine
11
Doxorubicin
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Bendamustine Hydrochloride
9
pembrolizumab
7
venetoclax
6
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Nivolumab
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Sorafenib
×
90 days
×
Clear all
No trials found.